Navigation Links
Malaysian Healthcare Industry Is in Good Shape
Date:1/15/2009

Country's healthcare industry in 2009 is expected to grow at 8 percent

MALAYSIA, Jan. 15 /PRNewswire/ -- The recent economic downturn has contributed to a significant shift in the Healthcare industry in 2009 regionally, but not for Malaysia.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)

Dr Pawel Suwinski, Senior Consultant of the Healthcare Practice, Asia Pacific comments that the Malaysian healthcare companies are not going to be affected as badly as it may seem.

"Malaysian economy is faring better as compared to other APAC countries. This is due to adequate monetary and fiscal responses, more resilient banking sector, and positive BOP: mostly accredited to oil export. As predicted, the more affected industries are manufacturing, electronics and automotive. The outlook for healthcare remains cautiously optimistic provided oil prices will not go up, China will not slump into recession and the US financial market will not collapse," he comments.

The country's healthcare industry in 2009 is expected to grow at 8 percent and is being supported by RM 13.7 billion budget (RM 13 billion in 2008). This is an increase of 5.35 percent from previous year, which represents 2 percent of GDP.

Tham Lin Hui, Senior Consultant of Pharmaceuticals Healthcare, Asia Pacific also echoes that the recent economy crisis presents an array of opportunities to key players in the pharmaceutical industry. It is estimated that the country's pharmaceutical industry will expand at a 5 percent rate.

"We can expect higher corporate activities with possible mergers & acquisitions. Players in this sector will be adopting new technologies (molecular, genetic) in the production of vaccines and therapeutic drugs will be the trend," Tham comments.

In a recent interview with the Managing Director of Kotra Pharma, Jimmy Piong says, the company will continue to invest in the development of a new range of products in anticipating of the growing demand for generic drugs as well as brand building activities to increase market share.

"Not just pharmaceutical alone, healthcare providers are also looking to increase their market share in the year 2009, with KPJ, Parkway, Sime Darby Healthcare, and Columbia Pacific/Asia vying for potential acquisitions and expansions as seen recently," adds Tham.

The healthcare industry is perceived more as a defensive in comparison to other industries. More often than not products are viewed as essential goods that should be less affected by cyclical economic events.

Healthcare companies see the global economy crisis as an opportunity in emerging markets. Companies are prepared to take bold steps with acquisitions or joint ventures with niche medical technology players in China & India such as Meditronics, Alpha X-ray & Shinva.

The pharmaceutical industry on the other hand foresee opportunities for investment by foreign companies in the form of clinical research outsourcing and clinical trials. The rest of the players such as medical devices and healthcare services provider will have a fare share of opportunity in biotechnology based products as well as expansion abroad.

Despite the economy meltdown, opportunities are anticipated for the Asia Pacific region especially Malaysia. Being one of the countries with excellent infrastructure and facilities as well as cost-competitiveness compared with other developing APAC nations, Malaysia healthcare industry is likely to gain the most out of this global economy condition.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best in class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best practice models to drive the generation, evaluation and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from 31 offices on six continents. To join our Growth Partnership, please visit http://www.frost.com.

    Contact:
    Emmie Kaur
    Corporate Communications - Healthcare, Asia Pacific
    DID: +603 6204 5913
    Mobile: +6012 801 9886
    Email: emmie.kaur@frost.com


'/>"/>
SOURCE Frost & Sullivan
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Keryx Biopharmaceuticals to Present at the J.P. Morgan 27th Annual Healthcare Conference
2. Schering-Plough to Webcast Presentation at 27th Annual J.P. Morgan Healthcare Conference
3. Endo Pharmaceuticals to Present at the J.P. Morgan 27th Annual Healthcare Conference
4. InteKrin Therapeutics to Present at the 27th Annual JP Morgan Healthcare Conference on Tuesday, January 13
5. Ikaria(R) to Present at 27th Annual JPMorgan Healthcare Conference
6. BioCryst to Present at the J.P. Morgan 27th Annual Healthcare Conference
7. ARCA biopharma to Present at 27th Annual JPMorgan Healthcare Conference
8. Dendreon Announces Webcast Presentation at 27th Annual J.P. Morgan Healthcare Conference
9. Arena Pharmaceuticals to Present at the 27th Annual J.P. Morgan Healthcare Conference
10. Amgen to Present at the 27th Annual JP Morgan Healthcare Conference
11. Par Pharmaceutical to Present at the 27th Annual J.P. Morgan Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... December 8, 2016 AskLinkerReports.com has published ... titled Global Amyloglucosidase Industry 2016 Market Research Report. From a ... industry chain overview are all covered in the report. This ... investment return analysis of the Amyloglucosidase industry. ... , , ...
(Date:12/8/2016)... 8, 2016  Renova™ Therapeutics, a biotechnology company ... and type 2 diabetes, announced that it has ... virus (AAV) vector developed in the laboratory of ... Stanford University. The company plans to use this ... product pipeline. "Early research has ...
(Date:12/8/2016)... ... December 08, 2016 , ... The ability ... optogenetics — is key to exciting advances in the study and mapping of ... projected via free-space optics stimulates small, transparent organisms and excites neurons within superficial ...
(Date:12/8/2016)... 2016 Oxford Gene ... seine Palette an anpassbaren SureSeq™ NGS-Panels mit dem ... das ein schnelles und kostengünstiges Studium der Varianten ... eine Erkennung von Einzel-Nukleotid-Variationen (Single Nucleotide Variation, SNV) ... kleinen Panel und ermöglicht eine individuelle Anpassung durch ...
Breaking Biology Technology:
(Date:12/7/2016)... According to a new market research report "Emotion Detection and Recognition Market ... Application Area, End User, And Region - Global Forecast to 2021", published by ... 2016 to USD 36.07 Billion by 2021, at a Compound Annual Growth Rate ... ... MarketsandMarkets Logo ...
(Date:12/6/2016)... -- Valencell , the leading innovator in performance ... third consecutive year of triple digit growth for its ... a 360 percent increase in companies who have acquired ... by sales of its wrist and ear Benchmark™ sensor ... for hearables for fitness and healthcare applications. ...
(Date:11/30/2016)... 30, 2016 Not many of us realize that we spend ? of ... we need to do it well. Inadequate sleep levels have been found to lead ... diabetes, and even cancer. Maybe now is the best time to rethink ... them to manage their sleep quality? Continue Reading ... ...
Breaking Biology News(10 mins):